Preliminary data from 23andMe’s ongoing genetic study of COVID-19 appears to lend more evidence for the importance of a person’s blood type — determined by the ABO gene — in differences in the susceptibility to the virus.
Scientists around the world are racing to understand COVID-19 and the novel coronavirus that causes the disease. Could genetics play a role?
During this global health crisis, 23andMe is activating its millions of consenting research participants to help contribute to our collective understanding of the new virus that causes COVID-19. This week, 23andMe scientists began a study of COVID-19, to understand how genetics may influence the differences in severity of the disease among people.
This month, the American Academy of Family Physicians host their annual Family Medicine Experience in Philadelphia, their largest meeting meant to inspire medical professionals focused on family medicine and primary care. The emergence of DTC genetic testing and questions from healthcare professionals such as family doctors surrounding this topic, have made it important for companies like 23andMe to have a presence.
We sometimes hear misconceptions from healthcare professionals about what we do at 23andMe, especially when discussing our health reports. This post is meant to address the most common misunderstandings in hopes that we can provide some clarity and improve understanding of the 23andMe experience.
Our Medical Education program supports HCPs who want to incorporate DTC genetic testing into patient care. By learning more about our service, HCPs will be more prepared to have meaningful conversations with their patients who want to discuss 23andMe reports.
At a meeting of the ADA Annual Conference on June 10th, 23andMe’s Senior Product Scientist, Michael Multhaup, Ph.D., will be presenting some of what we’ve learned in a presentation titled “Polygenic Risk Score Predicts Type 2 Diabetes Susceptibility in a Diverse Consumer Genetic Database.”
Put up your feet and check out two new 23andMe trait reports that look all the way down to your toes. Using a statistical model and data from almost half a million 23andMe research consented participants, we report a customer’s predisposition toward having bunions or flat feet. No small feat, this new set of trait reports brings the total number of trait reports to more than 30 for 23andMe Health + Ancestry Service customers.
Starting today, 23andMe Health + Ancestry Service customers can access a new Health Community page, focused on hypertrophic cardiomyopathy (HCM), the most common form of inherited heart disease.
"Mom, I’m not the best poet and I know you know it, but here’s my rhyme, I’ll try not to blow it."
